Shares of Emcure Pharmaceuticals rose 2.99% to Rs 1,836.50 on Monday after Motilal Oswal initiated coverage on the stock with a Buy rating and a target price of Rs 2,260, implying a potential upside of 23% from the current market price.Motilal Oswal said, "Emcure is implementing efforts to enhance differentiated offerings to both DF and international markets through its own R&D and acquired produc...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, fund raising, and order wins, here’s a quick look at which stocks will be in focus in today's trade:Results TodayIndian Oil Corporation, Afcons Infrastructure, Ola Electric Mobility, Apollo Micro Systems, Astral, DOMS Industries, Gujarat Narmada Valley Fertilizers & Chemicals...

Equity benchmarks shed over 2 percent on March 27 after a two-day relief rally, following the West Asia crisis and elevated oil prices. Market breadth weakened, with 2,668 shares declining against 374 advancing on the NSE. The market may attempt a rebound after a sharp correction, but sustainability is key to watch. Below are some short-term trading ideas to consider:Rajesh Palviya, Senior Vice Pr...

Equity benchmarks witnessed a relief rally of around 1.8 percent on March 24, supported by improved market breadth. Approximately 2,315 shares saw buying interest, compared to 695 declining shares on the NSE. The market is expected to undergo consolidation with range-bound trading over the next couple of sessions. Below are some short-term trading ideas to consider:Ashish Kyal, Founder and CEO of ...

The benchmark indices gained nearly 1 percent after a severe fall in the previous couple of sessions, with market breadth favouring the bulls on March 10. About 2,351 shares advanced compared to 587 declining shares on the NSE. The market is expected to see consolidation with range-bound trading in the next few sessions. Below are some short-term trading ideas to consider:Amol Athawale, VP Technic...